Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1326 ARTÍCULOS , VIENDO DEL 241 AL 255

Cholesterol in Alzheimer's disease and other amyloidogenic disorders

Harris JR, Milton NG.

Subcell Biochem. 2010;51:47-75. doi: 10.1007/978-90-481-8622-8_2.

From alpha to omega with Abeta: targeting the multiple molecular appearances of the pathogenic peptide in Alzheimer's disease

De Kimpe L, Scheper W.

Curr Med Chem. 2010;17(3):198-212. doi: 10.2174/092986710790149765.

Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease?

Johnson VE, Stewart W, Smith DH.

Nat Rev Neurosci. 2010 May;11(5):361-70. doi: 10.1038/nrn2808.

Convergence of amyloid-beta and tau pathologies on mitochondria in vivo

Eckert A, Schulz KL, Rhein V, Götz J.

Mol Neurobiol. 2010 Jun;41(2-3):107-14. doi: 10.1007/s12035-010-8109-5. Epub 2010 Mar 9.

Methylphenidate for apathy and functional status in dementia of the Alzheimer type

Padala PR, Burke WJ, Shostrom VK, Bhatia SC, Wengel SP, Potter JF, Petty F.

Am J Geriatr Psychiatry. 2010 Apr;18(4):371-4. doi: 10.1097/JGP.0b013e3181cabcf6.

Treatment of Alzheimer's disease with a cholinesterase inhibitor combined with antioxidants

Cornelli U.

Neurodegener Dis. 2010;7(1-3):193-202. doi: 10.1159/000295663. Epub 2010 Mar 12.

Validation of MRI-based 3D digital atlas registration with histological and autoradiographic volumes: an anatomofunctional transgenic mouse brain imaging study

Lebenberg J, Hérard AS, Dubois A, Dauguet J, Frouin V, Dhenain M, Hantraye P, Delzescaux T.

Neuroimage. 2010 Jul 1;51(3):1037-46. doi: 10.1016/j.neuroimage.2010.03.014. Epub 2010 Mar 10.

Effects of rivastigmine on common symptomatology of Alzheimer's disease (EXPLORE)

Gauthier S, Juby A, Dalziel W, Réhel B, Schecter R; EXPLORE investigators.

Curr Med Res Opin. 2010 May;26(5):1149-60. doi: 10.1185/03007991003688888.

Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease

Leung KK, Barnes J, Ridgway GR, Bartlett JW, Clarkson MJ, Macdonald K, Schuff N, Fox NC, Ourselin S; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2010 Jul 15;51(4):1345-59. doi: 10.1016/j.neuroimage.2010.03.018. Epub 2010 Mar 15.

A dual activity of ROS and oxidative stress on adult neurogenesis and Alzheimer's disease

Taupin P.

Cent Nerv Syst Agents Med Chem. 2010 Mar;10(1):16-21. doi: 10.2174/187152410790780172.

Group II metabotropic glutamate receptor stimulation triggers production and release of Alzheimer's amyloid(beta)42 from isolated intact nerve terminals

Kim SH, Fraser PE, Westaway D, St George-Hyslop PH, Ehrlich ME, Gandy S.

J Neurosci. 2010 Mar 17;30(11):3870-5. doi: 10.1523/JNEUROSCI.4717-09.2010.

Treatment of Alzheimer's disease: symptomatic and disease-modifying approaches

Galimberti D, Scarpini E.

Curr Aging Sci. 2010 Feb;3(1):46-56. doi: 10.2174/1874609811003010046.

Alzheimer's disease and amyloid beta-peptide deposition in the brain: a matter of 'aging'?

Moro ML, Collins MJ, Cappellini E.

Biochem Soc Trans. 2010 Apr;38(2):539-44. doi: 10.1042/BST0380539.

Potential role of acrolein in neurodegeneration and in Alzheimer's disease

Dang TN, Arseneault M, Murthy V, Ramassamy C.

Curr Mol Pharmacol. 2010 Jun;3(2):66-78.

Alzheimer's disease and tauopathy studies in flies and worms

Wentzell J, Kretzschmar D.

Neurobiol Dis. 2010 Oct;40(1):21-8. doi: 10.1016/j.nbd.2010.03.007. Epub 2010 Mar 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias